Clearmind Medicine Inc.
CMND · NASDAQ
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $172 | $30 | $415 | $263 |
| - Cash | $7 | $5 | $0 | $5 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $166 | $24 | $415 | $258 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | -$9 | -$8 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$12 | -$9 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.36 | -59.04 | -216.75 | -120.34 |
| % Growth | 96% | 72.8% | -80.1% | – |
| Operating Cash Flow | -$5 | -$6 | -$5 | -$3 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$5 | -$6 | -$5 | -$3 |